Immuneering Corporation
Price Action
Technical Summary
WEAKENINGImmuneering Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 26), showing significant lag compared to the market leaders. Earnings growth of 50% provides fundamental context to the price action. Investors should exercise caution due to high volatility (105% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.36 | +15.70% | ABOVE |
| 50 SMA | $4.96 | +1.78% | ABOVE |
| 100 SMA | $5.07 | -0.32% | BELOW |
| 150 SMA | $5.36 | -5.86% | BELOW |
| 200 SMA | $5.74 | -12.01% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is IMRX in an uptrend right now?
IMRX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is IMRX overbought or oversold?
IMRX's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is IMRX outperforming the market?
IMRX has a Relative Strength (RS) Rating of 26 out of 99. IMRX is currently lagging the broader market.
Where is IMRX in its 52-week range?
IMRX is trading at $5.05, which is 50% of its 52-week high ($10.08) and 30% above its 52-week low ($2.90).
How volatile is IMRX?
IMRX has a Beta of 0.77 and 52-week volatility of 105%. It's less volatile than the S&P 500 - generally more stable.